Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

被引：3
|
作者：
Kourie, Hampig Raphael [1 ]
Awada, Gil [2 ]
Awada, Ahmad Hussein [1 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, Brussels, Belgium
[2] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Brussels, Belgium
来源：
FUTURE ONCOLOGY | 2016年 / 12卷 / 04期
关键词：
cancer; checkpoint inhibitors; clinical trial; diagnosis; future; immunotherapies; ipilimumab; nivolumab; pembrolizumab; unknown primary tumor; NIVOLUMAB; ANTI-PD-1; SAFETY;
D O I：
10.2217/fon.15.329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：429 / 431
页数：3
相关论文
共 50 条
  • [41] Increasing cure rates of solid tumors by immune checkpoint inhibitors
    Ma, Weijie
    Xue, Ruobing
    Zhu, Zheng
    Farrukh, Hizra
    Song, Wenru
    Li, Tianhong
    Zheng, Lei
    Pan, Chong-xian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [42] Increasing cure rates of solid tumors by immune checkpoint inhibitors
    Weijie Ma
    Ruobing Xue
    Zheng Zhu
    Hizra Farrukh
    Wenru Song
    Tianhong Li
    Lei Zheng
    Chong-xian Pan
    Experimental Hematology & Oncology, 12
  • [43] Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
    Oladejo, Mariam
    Paulishak, Wyatt
    Wood, Laurence
    SEMINARS IN CANCER BIOLOGY, 2023, 88 : 81 - 95
  • [44] Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
    Zou, Wenlu
    Lu, Jie
    Hao, Yan
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3077 - 3088
  • [45] The role of immune checkpoint inhibitors in triple negative breast cancer: recent developments and future perspectives
    Papadimitriou, Marios
    Liakouli, Zoi
    Papadimitriou, Christos A.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [46] Combination Therapy of Primary Tumor Resection and Immune Checkpoint Inhibitors for Metastases of Osteosarcoma: A Promising Therapeutic Strategy
    Shimizu, T.
    Fuchimoto, Y.
    Fukuda, K.
    Okita, H.
    Kitagawa, Y.
    Kuroda, T.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S345 - S345
  • [47] Is there a role for therapeutic cancer vaccines in the age of checkpoint inhibitors?
    Dillman, Robert O.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 528 - 532
  • [48] The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
    Andrew S. Luksik
    Russell Maxwell
    Tomas Garzon-Muvdi
    Michael Lim
    Neurotherapeutics, 2017, 14 : 1049 - 1065
  • [49] The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors
    Luksik, Andrew S.
    Maxwell, Russell
    Garzon-Muvdi, Tomas
    Lim, Michael
    NEUROTHERAPEUTICS, 2017, 14 (04) : 1049 - 1065
  • [50] Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
    Makaremi, Shima
    Asadzadeh, Zahra
    Hemmat, Nima
    Baghbanzadeh, Amir
    Sgambato, Alessandro
    Ghorbaninezhad, Farid
    Safarpour, Hossein
    Argentiero, Antonella
    Brunetti, Oronzo
    Bernardini, Renato
    Silvestris, Nicola
    Baradaran, Behzad
    BIOMEDICINES, 2021, 9 (09)
12345